Findings will help scientists understand how microgravity impacts the ability of human heart cells to withstand the stresses of space travel
November 16, 2023
Mount Sinai Bioengineers Send Cardiac Muscle Samples Into Space to Study Heart Cell Biology in Microgravity
November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells…
Read More
In the trial of more than 400 adults with heart failure in Israel, the app predicted the need for hospitalization about three weeks in advance of a heart failure event
November 16, 2023
AI-phone App Detected Worsening Heart Failure Based on Changes in Patients’ Voices
November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a…
Read More
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States
November 15, 2023
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy
November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first…
Read More
Researchers at the University of Leicester have discovered the mechanism by which cholesterol in our diet is absorbed into our cells
November 15, 2023
Ground-breaking Discovery Could Pave the Way for New Therapies to Prevent Cardiovascular Disease and Stroke
November 15, 2023 — Researchers at the University of Leicester have discovered the mechanism by which cholesterol in…
Read More
Real-world evidence from the AHA Scientific Sessions 2023 demonstrated that Eko's AI doubles valvular heart disease detection sensitivity over traditional methods
November 15, 2023
Multicenter Validation of the Novel Vivio System for Non-Invasive Estimation of Elevated Left Ventricular End Diastolic Pressure
November 15, 2023 — Ventric Health, a healthcare technology company and medical device provider focused on…
Read More
The global medical technology leader and international medical imaging IT and cybersecurity company are working together to provide clinicians with a thorough workflow integration that spans from orchestration and diagnostics to report generation and result distribution
November 14, 2023
GE HealthCare and Sectra Plan to Leverage Deep Integration to Help Enhance Clinical Efficiency
November 14, 2023 — To help provide clinicians a comprehensive workflow, GE HealthCare is working towards the seamless…
Read More
The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science
November 14, 2023
American Heart Association Honors Gladstone President Deepak Srivastava with Distinguished Scientist Award
November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher,…
Read More
Real-world evidence from the AHA Scientific Sessions 2023 demonstrated that Eko's AI doubles valvular heart disease detection sensitivity over traditional methods
November 14, 2023
Breakthrough Clinical Data: Eko Health's AI Significantly Improves Heart Disease Detection in Primary Care
November 14, 2023 — Eko Health, Inc., a leader in AI technology for heart and lung disease detection, today unveiled…
Read More
Visage introduces Visage 7, Cardiology Imaging and Visage 7 RadPath Hub
November 13, 2023
Visage Soars with CloudPACS at RSNA 2023
November 13, 2023 — Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd., has announced it will be…
Read More
Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias
November 13, 2023
Exciting New Applications of vMap for Ventricular Arrhythmias Highlighted at AHA 2023
November 13, 2023 — Vektor Medical, a pioneer in non-invasive arrhythmia analysis technology, is proud to highlight two…
Read More
Ultromics, a leading health technology company at the forefront of detection of heart failure and its phenotypes, announces a significant development regarding the reimbursement code for its flagship product, EchoGo Heart Failure.
November 13, 2023
CMS publishes final Clinical APC rule for Ultromics EchoGo Heart Failure
November 13, 2023 — Ultromics, a leading health technology company at the forefront of detection of heart failure and…
Read More
Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023, AHA 2023, which compared the effects of high-sodium and low-sodium diets on blood pressure in adults, found that following a low-sodium diet significantly lowered blood pressure in 70%-75% of participants in as little as one week
November 11, 2023
Reducing Sodium Intake Significantly Lowered Blood Pressure in as Little as One Week, Reports AHA 2023 Late-Breaking Science Abstract
November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific…
Read More
Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.
November 11, 2023
Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association AHA 2023 Scientific Sessions
November 11, 2023 —  An announcement on partners to collaborate in the TRANSFORM trial was made today during the…
Read More
Getinge announced commercial availability of the iCast covered stent system in the United States
November 10, 2023
Getinge Announces U.S. Commercial Availability of iCast Covered Stent System for Treatment of Iliac Arterial Occlusive Disease
November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for…
Read More
Zerlasiran showed very significant and durable reductions in lipoprotein(a) of up to 99% Lp(a) levels remained around 90% lower than baseline at study endpoint
November 10, 2023
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to…
Read More
Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai.
November 10, 2023
Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023
November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at…
Read More
November 10, 2023
Total Artificial Heart Developer BiVACOR Mechanical Engineer Receives Sezai Innovation Award at ISMCS Annual Conference
November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has…
Read More
Further enhancing comprehensive trauma care solution
November 09, 2023
RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas
November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow…
Read More
Clinical trial data released during VIVA 2023 Conference included results from a study involving the Veryan Medical BioMimics 3D Vascular Stent System.
November 09, 2023
Final Round of Late-breaking Clinical Trial Results Announced at VIVA23
November 9, 2023 — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular…
Read More
The survey indicates the increased use of RPM to manage care both in clinics and home-based cardiac rehab settings
November 09, 2023
New Cardiac Rehabilitation Survey Reveals 93% of Healthcare Providers Currently Utilize Remote Patient Monitoring Technology
November 9, 2023 — According to a recent survey of healthcare providers (HCPs), 93 percent of clinicians are currently…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now